FDA advisers warn: COX 2 inhibitors increase risk of heart attack and stroke
- 24 February 2005
- Vol. 330 (7489), 440
- https://doi.org/10.1136/bmj.330.7489.440
Abstract
No abstract availableThis publication has 1 reference indexed in Scilit:
- Comparison of Upper Gastrointestinal Toxicity of Rofecoxib and Naproxen in Patients with Rheumatoid ArthritisNew England Journal of Medicine, 2000